ELK1-YBX1 signaling promotes cisplatin resistance via ferroptosis adaptation in bladder cancer. Luo Y, Ma J, Wang C, Xiong W, et al. Cell Signal 2026 Jun 1:112633. doi: 10.1016/j.cellsig.2026.112633.

Read + Share

Amedeo Smart

Independent Medical Education

Luo Y, Ma J, Wang C, Xiong W, et al. ELK1-YBX1 signaling promotes cisplatin resistance via ferroptosis adaptation in bladder cancer. Cell Signal 2026 Jun 1:112633. doi: 10.1016/j.cellsig.2026.112633.
PMID: 42229737